glp-1 colitis nanomedicine alleviates gut inflammation Glucagon-like peptide-1 (GLP-1) receptor agonists

Journal of Pharmacy & Bioallied Sciences

All GLP-1 agonists labeled for weight reduction in cases of obesity or overweight plus one weight-related comorbidity must be combined with a reduced-calorie diet and increased physical activity

Mar 10, 2026 Diabetes, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,046 views Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of type 2 diabetes and obesity

Some patients may tolerate one medication better than the other, and our team at Elite Primary Care Group will help you weigh the options based on your individual needs and medical history

Impaired sensitivity to thyroid hormones is associated with hyperuricemia, obesity, and cardiovascular disease risk in subjects with subclinical hypothyroidism

A heart rate increase of 5 to 10 BPM without symptoms is expected and generally acceptable